Gianmaria Cammarota to Tumor Necrosis Factor-alpha
This is a "connection" page, showing publications Gianmaria Cammarota has written about Tumor Necrosis Factor-alpha.
Connection Strength
0.021
-
Body mass index influences infliximab post-infusion levels and correlates with prospective loss of response to the drug in a cohort of inflammatory bowel disease patients under maintenance therapy with Infliximab. PLoS One. 2017; 12(10):e0186575.
Score: 0.021